Monash Medical Centre is a teaching hospital in Melbourne, Australia. It provides specialist tertiary-level healthcare to the Melbourne's south-east. Monash Medical Centre is part of Monash Health, the largest public health service in Victoria.

There are 640 beds in Monash Medical Centre.

During the past decade, Monash Medical Centre conducted 311 clinical trials. In the 10-year time frame, 311 clinical trials started and 117 clinical trials were completed, i.e. on average, 37.6% percent of trials that started reached the finish line to date. In the past 5 years, 150 clinical trials started and 76 clinical trials were completed. i.e. 50.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Monash Medical Centre" #1 sponsor was "Gilead Sciences" with 23 trials, followed by "Pfizer" with 22 trials sponsored, "BeiGene" with 21 trials sponsored, "Boston Scientific Corporation" with 17 trials sponsored and "Celgene" with 17 trials sponsored. Other sponsors include 343 different institutions and companies that sponsored additional 201 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Monash Medical Centre" #1 collaborator was "National Health and Medical Research Council, Australia" with 15 trials as a collaborator, "National Cancer Institute (NCI)" with 12 trials as a collaborator, "AstraZeneca" with 7 trials as a collaborator, "Monash University" with 7 trials as a collaborator and "Merck Sharp & Dohme LLC" with 5 trials as a collaborator. Other collaborators include 343 different institutions and companies that were collaborators in the rest 268 trials.

According to Clinical.Site data, the most researched conditions in "Monash Medical Centre" are "Coronary Artery Disease" (14 trials), "Crohn's Disease" (8 trials), "Ulcerative Colitis" (8 trials), "Crohn Disease" (7 trials) and "Prostate Cancer" (7 trials). Many other conditions were trialed in "Monash Medical Centre" in a lesser frequency.

Most popular intervention types in "Monash Medical Centre" are "Drug" (347 trials), "Other" (51 trials), "Device" (47 trials), "Biological" (42 trials) and "Procedure" (21 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (98 trials), "Cyclophosphamide" (13 trials), "Dexamethasone" (10 trials), "Cytarabine" (9 trials) and "Paclitaxel" (9 trials). Other intervention names were less common.

The vast majority of trials in "Monash Medical Centre" are 420 trials for "All" genders, 16 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are 192 active trials in "Monash Medical Centre". 2 are not yet recruiting, 101 are recruiting, 86 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 191 completed trials in Monash Medical Centre, 1 suspended trials, and 48 terminated clinical trials to date.

Out of the total trials that were conducted in Monash Medical Centre, 83 "Phase 1" clinical trials were conducted, 134 "Phase 2" clinical trials and 190 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 19 trials, and there were also 43 trials that are defined as “Not Applicable".